Advertisement

Lebertransplantation und Leberversagen

  • Rainer Ganschow
  • Michael Melter
  • Johann Deutsch

Zusammenfassung

Es kann geschätzt werden, dass etwa 2 von 10.000 Neugeborenen oder 1–2 Neugeborene pro 1 Mio. Einwohner jährlich auf eine Lebertransplantation angewiesen sein werden.

Literatur

Literatur zu Abschn. 19.1

  1. Arora-Gupta N, Davies P, McKiernan P, Kelly DA (2004) The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation. Pediatr Transplantation 8: 145–150CrossRefGoogle Scholar
  2. Brinkert F, Kemper MJ, Briem-Richter A et al. (2011) High prevalence of renal dysfunction in children after liver transplantation: non-invasive diagnosis using a cystatin C-based equation. Nephrol Dial Transplant 26: 1407–1412PubMedCrossRefGoogle Scholar
  3. Broering DC, Mueller L, Ganschow R et al. (2001) Is there still a need for living-related liver transplantation in children? Ann Surg 234: 713–722PubMedCrossRefGoogle Scholar
  4. Bucuvalas JC, Ryckman FC (2002) Long-term outcome after liver transplantation in children. Pediatr Transplantation 6: 30–36CrossRefGoogle Scholar
  5. Burdelski M, Nolkemper D, Ganschow R et al. (1999) Liver transplantation in children: Long-term outcome and quality of life. Eur J Pediatr 158(Suppl 2): S34–S42CrossRefGoogle Scholar
  6. Fine RN (2002) Growth following solid-organ transplantation. Pediatr Transplantation 6: 47–52CrossRefGoogle Scholar
  7. Ganschow R (Hrsg) (2003) Immunsuppression in der pädiatrischen Transplantationsmedizin. Uni-Med, BremenGoogle Scholar
  8. Ganschow R, Nolkemper D, Helmke K et al. (2000) Intensive care management after pediatric liver transplantation: a single center experience. Pediatr Transplantation 4: 273–279CrossRefGoogle Scholar
  9. Ganschow R, Broering DC, Nolkemper D (2001a) Th2 cytokine profile in infants predisposes to improved graft acceptance after pediatric liver transplantation. Transplantation 72: 929–934CrossRefGoogle Scholar
  10. Ganschow R, Broering DC, Stuerenburg I et al. (2001b) First experience with basiliximab in pediatric liver graft recipients. Pediatr Transplantation 5: 353–357CrossRefGoogle Scholar
  11. Ganschow R, Grabhorn E, Helmke K, Rogiers X, Burdelski M (2001c) Liver transplantation in children with Alagille Syndrome. Transpl Proc 33: 3608–3609CrossRefGoogle Scholar
  12. Ganschow R, Schulz T, Meyer T, Broering D, Burdelski M (2004) Low-dose immunosuppression reduces the incidence of posttransplant lymphoproliferative disease in pediatric liver graft recipients. J Pediatr Gastroenterol Nutr 38: 198–203PubMedCrossRefGoogle Scholar
  13. Grabhorn E, Schulz A, Helmke K et al. (2004) Short- and long-term results of liver transplantation in infants aged less than 6 months. Transplantation 78: 235–241PubMedCrossRefGoogle Scholar
  14. Halme L, Hoeckerstedt K, Lautenschlager I (2003) Cytomegalovirus infection and development of biliary complications after liver transplantation. Transplantation 75: 1853–1858PubMedCrossRefGoogle Scholar
  15. Kaller T,Langguth N, Ganschow R et al. (2010) Attention and executive functioning deficits in liver transplanted children. Transplantation 90: 1567–1573PubMedCrossRefGoogle Scholar
  16. Kelly DA (2001) Optimal immunosuppression in teenagers. Pediatr Transplantation 6: 480–487CrossRefGoogle Scholar
  17. Kovarik J, Mueller E, Bree JV et al. (1994) Cyclosporine pharmakokinetics and variability from a microemulsion formulation – a multicenter investigation in kidney transplant patients. Transplantation 58: 444–448Google Scholar
  18. Martin SR, Atkison P, Anand R, Lindblad AS and the SPLIT Research Group (2004) Studies of pediatric liver transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplantation 8: 273–283CrossRefGoogle Scholar
  19. Mazariegos GV, Reyes J, Webber SA et al. (2002) Cytokine gene polymorphisms in children successfully withdrawn from immunosuppression after liver transplantation. Transplantation 73: 1342–1346PubMedCrossRefGoogle Scholar
  20. Meyer-Koenig U, Weidmann M, Kirste G, Hufert FT (2004) Cytomegalovirus infection in organ-transplant recipients: diagnostic value of pp65 antigen test, qualitative polymerase chain reaction (PCR) and qualitative taqman PCR. Transplantation 77: 1692–1698PubMedCrossRefGoogle Scholar
  21. Roberts JP, Hulbert-Shearon TE, Merion RM, Wolfe RA, Port FK (2004) Influence of graft type on outcomes after pediatric liver transplantation. Am J Transplantation 4: 373–377CrossRefGoogle Scholar
  22. Schulz KH, Wein C, Boeck A, Rogiers X, Burdelski M (2003) Cognitive performance of children who have undergone liver transplantation. Transplantation 75: 1236–1240PubMedCrossRefGoogle Scholar
  23. Spada M, Silvia R, Maggione G et al. (2009) Pediatric liver transplantation. World J Gasroenterol 15(6): 648–674CrossRefGoogle Scholar
  24. Starzl TE (1969) Experience in hepatic transplantation. Saunders, PhiladelphiaGoogle Scholar
  25. Whittington PF, Alonso EM, Superina RA, Freese DK (2002) Liver transplantation in children. J Pediatr Gastroenterol Nutr 35: S44–S50CrossRefGoogle Scholar

Literatur zu Abschn. 19.2

  1. Arya R, Gulati S, Deopujari S (2010) Management of hepatic encephalopathy in children. Postgrad Med J 86: 34–41PubMedCrossRefGoogle Scholar
  2. Baliga P, Alvarez S, Lindblad A, Zeng L (2004) Posttransplant survival in pediatric fulminant hepatic failure: the SPLIT experience. Liver Transpl 10: 1364–1371PubMedCrossRefGoogle Scholar
  3. Baquerizo A, Anselmo D, Shackleton C et al. (2003) Phosphorus as an early predictive factor in patients with acute liver failure. Transplantation 75: 2007–2014PubMedCrossRefGoogle Scholar
  4. Bhaduri BR, Mieli-Vergani G (1996) Fulminant hepatic failure: pediatric aspects. Semin Liver Dis 16: 349–355PubMedCrossRefGoogle Scholar
  5. Brockstedt M, Giani G, Herzig P et al. (1997) ESPED-Jahresbericht 1996. Monatsschr Kinderheilkd 145: 1228–1233Google Scholar
  6. Carpentier B, Gautier A, Legallais C (2009) Artificial and bioartificial liver devices: present and future. Gut 58: 1690–1702 Melter M, Rodeck B, Brodehl J (1996) Akutes Leberversagen im Kindesalter. Monatsschr Kinderheilkd 144: 592–598PubMedCrossRefGoogle Scholar
  7. Chan G, Taqi A, Marotta P et al. (2009) Long-term outcomes of emergency liver transplantation for acute liver failure. Liver Transpl 15: 1696–1702PubMedCrossRefGoogle Scholar
  8. DeVictor D, Desplanques L, Debray D et al. (1992) Emergency liver transplantation for fulminant liver failure in infants and children. Hepatology 16: 1156–1162PubMedCrossRefGoogle Scholar
  9. Ekiz F, Yuksel I, Kertmen N, Yuksel O (2010) Liver toxicity due to broccoli juice. Eur J Gastroenterol Hepatol 22: 898PubMedCrossRefGoogle Scholar
  10. Faraj W, Dar F, Bartlett A et al. (2010) Auxiliary liver transplantation for acute liver failure in children. Ann Surg 251: 351–356PubMedCrossRefGoogle Scholar
  11. Gregory B, Larson AM, Reisch J, Lee WM (2010) Acetaminophen dose does not predict outcome in acetaminophen-induced acute liver failure. J Investig Med 58: 707–710PubMedGoogle Scholar
  12. Grothues D, Strassburg A, Knoppke B et al. (2003) Riesenzellhepatitis in Assoziation mit autoimmunhämolytischer Anämie und Immunthrombopenie – Erfolgreiche Remissionserhaltung unter einer Therapie mit Mycophenolat Mofetil (MMF). In: Behrens R, Deutsch J (Hrsg) Symposia Abstracts. sps Publications, Eustis/USA, p 92Google Scholar
  13. Harrison PM, Wendon JA, Gimson AE, Alexander GJ, Williams R (1991) Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 324: 1852–1857PubMedCrossRefGoogle Scholar
  14. Kamat P, Kunde S, Vos M et al. (2012) Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure. Pediatr Crit Care Med 13: e33–e38Google Scholar
  15. Khuroo MS, Kamili S (2003) Aetiology and prognostic factors in acute liver failure in India. J Viral Hepat 10: 224–231.PubMedCrossRefGoogle Scholar
  16. Kneiseler G, Bachmann HS, Bechmann LP et al. (2010) A rare case of propofol-induced acute liver failure and literature review. Case. Rep Gastroenterol 4: 57–65PubMedCrossRefGoogle Scholar
  17. Knoppke B, Grothues D, Vermehren J et al. (2011) Auxiliary liver transplantation in 2 children with acute liver failure. Transpl Int 24: 40CrossRefGoogle Scholar
  18. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH (2008) Acute liver failure: summary of a workshop. Hepatology 47: 1401–1415PubMedCrossRefGoogle Scholar
  19. Mahler H, Pasi A, Kramer JM et al. (1997) Fulminant liver failure in association with the emetic toxin of Bacillus cereus. N Engl J Med 336: 1142–1148PubMedCrossRefGoogle Scholar
  20. Melter M, Rodeck B, Kardorff R (1995) Liver transplantation for fulminant liver failure in childhood. Liver Transpl Surg 1: 5Google Scholar
  21. Melter M, Nashan B, Strassburg A et al. (2002) Die pädiatrische Lebertransplantation – Indikationen und Ergebnisse. TransplantLinc 4: 54–62Google Scholar
  22. Muller T, Langner C, Fuchsbichler A et al. (2004) Immunohistochemical analysis of Mallory bodies in Wilsonian and non-Wilsonian hepatic copper toxicosis. Hepatology 39: 963–969PubMedCrossRefGoogle Scholar
  23. Nguyen NT, Vierling JM (2011) Acute liver failure. Curr Opin Organ Transplant 16: 289–296PubMedCrossRefGoogle Scholar
  24. O'Grady JG, Alexander GJM, Hayllar KM, Williams R (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterol 97: 439–445Google Scholar
  25. Ozturk Y, Berktas S, Soylu OB et al. (2010) Fulminant hepatic failure and serum phosphorus levels in children from the western part of Turkey. Turk J Gastroenterol 21: 270–274PubMedGoogle Scholar
  26. Posfay-Barbe KM, Schrenzel J, Frey J et al. (2008) Food poisoning as a cause of acute liver failure. Pediatr Infect Dis J 27: 846–847PubMedCrossRefGoogle Scholar
  27. Ringe H, Varnholt V, Zimmering M et al. (2011) Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure. Pediatr Crit Care Med 12: 257–264PubMedCrossRefGoogle Scholar
  28. Rudnick DA, Dietzen DJ, Turmelle YP et al. (2009) Serum alpha-NH-butyric acid may predict spontaneous survival in pediatric acute liver failure. Pediatr Transplant 13: 223–230PubMedCrossRefGoogle Scholar
  29. Schaefer B, Schaefer F, Engelmann G et al. (2011) Comparison of Molecular Adsorbents Recirculating System (MARS) dialysis with combined plasma exchange and haemodialysis in a children with acute liver failure. Nephrol Dial Transplant 26: 3633–3639PubMedCrossRefGoogle Scholar
  30. Shanmugam NP, Dhawan A (2011) Selection criteria for liver transplantation in paediatric acute liver failure: the saga continues. Pediatr Transplant 15: 5–6PubMedCrossRefGoogle Scholar
  31. Stickel F, Patsenker E, Schuppan D (2005) Herbal hepatotoxicity. J Hepatol 43: 901–910PubMedCrossRefGoogle Scholar
  32. Thomson M, McKiernan P, Buckels J, Mayer D, Kelly D (1998) Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. J Pediatr Gastroenterol Nutr 26: 478–481PubMedCrossRefGoogle Scholar
  33. Vickers C, Neuberger J, Buckels J, McMaster P, Elias E (1988) Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol 7: 143–150 (1988).PubMedCrossRefGoogle Scholar
  34. Vogel A, Heinrich E, Bahr MJ et al. (2004) Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant 18: 62–69PubMedCrossRefGoogle Scholar

Literatur zu Abschn. 19.3

  1. Alcorn J, McNamara (2002) Ontogeny of hepatic and renal systemic clearance pathways in infants. Clin Pharmacokinet 41: 959–998PubMedCrossRefGoogle Scholar
  2. Alonso EA, Superina RA, Whitington PF (1999) Fulminant hepatitis and acute liver failure. In: Kelly DA (ed) Diseases of the liver and biliary system in children. Blackwell, Oxford, pp 77–94Google Scholar
  3. Balistreri WF, Stocker JT (1990) Pediatric hepatology. Hemisphere, New YorkGoogle Scholar
  4. Bass NM (2000) Toxic and drug-induced liver disease. In: Goldman L, Bennett JC (eds) Cecil textbook of medicine. Saunders, Philadelphia, pp 779–783Google Scholar
  5. Bijleveld CMA (1993) Toxic hepatitis. In: Buts J-P, Sokal EM (eds) Management of digestive and liver disorders in infants and children. Elsevier, Amsterdam, pp 595–601Google Scholar
  6. Bouwmeester NJ, Anderson BJ, Tibboel D, Holford NH (2004) Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. Br J Anaesth 92: 208–217PubMedCrossRefGoogle Scholar
  7. Colon AR (1990) Textbook of pediatric hepatology. Year Book, ChicagoGoogle Scholar
  8. Dienstag JL, Isselbacher KJ (2001) Toxic and drug-induced hepatitis. In: Braunwald E, Fauci AS, Hauser SL et al. (eds) Harrison’s principles of internal medicine. McGraw-Hill, New York, pp 1737–1742Google Scholar
  9. Fakhoury M, Jacqz-Aigrain E (2005) Developmental pharmacogenetics. Paediatrica 16: 28–31Google Scholar
  10. Gregus Z, Klaassen CD (1998) Hepatic disposition of xenobiotics during prenatal and early postnatal development. In: Polin RA, Fox WW (eds) Fetal and neonatal physiology. Saunders, Philadelphia, pp 1472–1493Google Scholar
  11. Johnson TN (2003) The development of drug metabolizing enzymes and their influence on the susceptibility to adverse drug reactions in children. Toxicology 192: 37–48PubMedCrossRefGoogle Scholar
  12. Kearns GL, Abdel-Rahman SM, Alander SW et al. (2003) Developmental pharmacology – drug disposition, action and therapy in infants and children. N Engl J Med 349: 1157–1167PubMedCrossRefGoogle Scholar
  13. Lacroix D, Sonnier M, Moncion A, Cheron G, Cresteil T (1997) Expression of CYP3 A in the human liver – evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. Eur J Biochem 247: 625–634PubMedCrossRefGoogle Scholar
  14. Mowat AP (1994) Liver disorders in childhood. Butterworth-Heinemann, OxfordGoogle Scholar
  15. Roberts EA (2007) Drug-induced liver disease. In: Suchy J, Sokol RJ, Balistreri WF (eds) Liver disease in children, 3rd edn. Cambridge University Press, Cambridge, pp 478–512CrossRefGoogle Scholar
  16. Stricker BHC, Spoelstra P (1985) Drug-induced hepatic injury. Elsevier, AmsterdamGoogle Scholar
  17. Zakim D, Boyer TD (2003) Hepatology. A textbook of liver disease. Saunders, PhiladelphiaGoogle Scholar
  18. Zhang-Xu L, Govindarajan S, Kaplowitz N (2004) Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 127: 1760–1774CrossRefGoogle Scholar
  19. Zimmerman HJ, Ishak KG (2002) Hepatic injury due to drugs and toxins. In: MacSween RNM, Ishak KG, Burt AD et al. (eds) Pathology of the liver. Churchill Livingstone, London, pp 621–709Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Rainer Ganschow
    • 1
  • Michael Melter
    • 2
  • Johann Deutsch
    • 3
  1. 1.Pädiatrische Hepatologie und LebertransplantationUniversitätsklinikum Hamburg-EppendorfHamburgDeutschland
  2. 2.Klinik und Poliklinik für Kinder- und JugendmedizinUniversitätsklinikum RegensburgRegensburgDeutschland
  3. 3.Universitätsklinik für Kinder- und Jugendheilkunde GrazGrazÖsterreich

Personalised recommendations